| Q48583669 | 1997 Sir William Refshauge Lecture. Skeletal muscle glucose metabolism during exercise: implications for health and performance |
| Q44067378 | A comparison between an in vitro method to determine carbohydrate digestion rate and the glycemic response in young men. |
| Q36019817 | A critical appraisal of the role of insulin analogues in the management of diabetes mellitus |
| Q74141517 | A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2) |
| Q35987436 | A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes. |
| Q36519198 | A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies |
| Q46577859 | A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats. |
| Q50953901 | A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. |
| Q85947879 | A randomised controlled trial evaluating the effect of potassium supplementation on vascular function and the renin-angiotensin-aldosterone system |
| Q44307875 | A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. |
| Q33993685 | A rational approach to drug therapy of type 2 diabetes mellitus |
| Q33678321 | A risk-benefit assessment of metformin in type 2 diabetes mellitus |
| Q51558281 | A switch in the direction of the effect of insulin on the partitioning of hepatic fatty acids for the formation of secreted triacylglycerol occurs in vivo, as predicted from studies with perfused livers. |
| Q43623047 | ACE gene polymorphism and insulin action in older subjects and healthy centenarians. |
| Q35859177 | Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans |
| Q74062714 | Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts |
| Q37690126 | Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis |
| Q36703010 | Adiposity is associated with endothelial activation in healthy 2-3 year-old children. |
| Q36606617 | Adolescents with metabolic syndrome have a history of low aerobic fitness and physical activity levels. |
| Q36007858 | Advances in diabetes for the millennium: the heart and diabetes |
| Q33723742 | Advancing age and insulin resistance: new facts about an ancient history |
| Q33804310 | Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test |
| Q33977523 | Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer |
| Q32164773 | Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians |
| Q43986915 | Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men. |
| Q50173912 | Alternative treatment of gallbladder disease |
| Q42162675 | Ambulatory blood pressure variability is increased in diabetic hypertensives |
| Q34617924 | Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors |
| Q34960686 | Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks |
| Q34505196 | Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology |
| Q55192988 | Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. |
| Q34559780 | Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using JCR:LA-cp rat. |
| Q43589213 | Anti-lipolytic effects of insulin in African American and white prepubertal boys |
| Q37921893 | Antiatheromatic effects of insulin |
| Q34112906 | Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus? |
| Q28209964 | Approaches to prevention of cardiovascular complications and events in diabetes mellitus |
| Q51479251 | Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity? |
| Q37244032 | Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices |
| Q40697207 | Assessment of the usefulness of skin autofluorescence as an indicator of disease activity and of the risk of developing diabetes in patients suffering from rheumatoid arthritis |
| Q92137314 | Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT |
| Q37341485 | Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis |
| Q53707452 | Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study. |
| Q44416991 | Association between postprandial hyperinsulinemia and coronary artery disease among non-diabetic women: a case control study |
| Q73189707 | Association between weight fluctuation and fasting insulin concentration in Japanese men |
| Q51571423 | Association of insulin levels with lipids and lipoproteins in elderly Japanese-American men. |
| Q34552004 | Association of insulin resistance indexes to carotid intima-media thickness |
| Q74036367 | Association of insulin with QTc dispersion |
| Q53669072 | Association of physical activity and visceral adipose tissue in older women and men. |
| Q47987163 | Associations between skeletal muscle properties, physical fitness, physical activity and coronary heart disease risk factors in men. |
| Q36432385 | Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients |
| Q73423924 | Atherosclerosis and arteriosclerosis in chronic renal failure |
| Q35023612 | Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets |
| Q51561695 | Atherosclerosis seems not to be associated with hyperinsulinaemia in patients with familial hypercholesterolaemia. |
| Q41988851 | Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease |
| Q33706452 | Basal hyperinsulinemia beyond a threshold predicts major adverse cardiac events at 1 year after coronary angiogram in type 2 diabetes mellitus: a retrospective cohort study |
| Q34152782 | Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus |
| Q33703334 | Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus |
| Q51536777 | Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. |
| Q45111558 | Biochemical alterations and liver toxicity analysis with pioglitazone in healthy subjects |
| Q45105498 | Biomarkers of vascular inflammation and subclinical atherosclerosis in the metabolic syndrome |
| Q44848288 | Bivariate linkage between acylation-stimulating protein and BMI and high-density lipoproteins |
| Q41719625 | Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease |
| Q46651394 | Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with Omega-3 polyunsaturated fatty acids |
| Q44572740 | C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients |
| Q43265725 | CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up. |
| Q36483455 | Can PPARgamma agonists have a role in the management of obesity-related hypertension? |
| Q36993722 | Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets |
| Q39773232 | Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography |
| Q30438641 | Cardiovascular disease and risk factors in three Alaskan Eskimo populations: the Alaska-Siberia project |
| Q44620555 | Cardiovascular disease in South Asians |
| Q29353881 | Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review |
| Q37103095 | Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31. |
| Q45937038 | Cardiovascular risk continuum: implications of insulin resistance and diabetes. |
| Q75447914 | Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study) |
| Q45198801 | Cardiovascular risk factors in overweight and obese Chinese children: a comparison of weight-for-height index and BMI as the screening criterion |
| Q34013831 | Cardiovascular risk in diabetes: a brief review |
| Q34164119 | Cardiovascular risk in type 2 diabetes |
| Q33575570 | Cardiovascular risk may be increased in women with unexplained infertility |
| Q51490006 | Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. |
| Q44094088 | Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure |
| Q33704490 | Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore |
| Q57054899 | Changes in body composition and metabolic disease risk |
| Q43725908 | Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea |
| Q33857313 | Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats |
| Q34939164 | Childhood obesity and cardiovascular disease: links and prevention strategies |
| Q34390688 | Chromium Therapy for Insulin Resistance Associated with HIV-Disease |
| Q46812196 | Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study |
| Q36407271 | Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart |
| Q39146317 | Clinical and biochemical predictors of increased carotid intima-media thickness in overweight and obese adolescents with type 2 diabetes |
| Q33842437 | Clinical implications of the insulin resistance syndrome |
| Q46419672 | Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure? |
| Q24794239 | Clinical significance of cardiovascular dysmetabolic syndrome |
| Q50869061 | Clustering of cardiovascular risk factors in hyperinsulinemia in Japanese without diabetes. |
| Q33975723 | Combinatorial administration of insulin and vitamin C alleviates the cerebral vasospasm after experimental subarachnoid hemorrhage in rabbit |
| Q92127319 | Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats |
| Q41739316 | Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans |
| Q42138635 | Comparison between serum insulin levels and its resistance with biochemical, clinical and anthropometric parameters in South Indian children and adolescents |
| Q33585627 | Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus |
| Q45337960 | Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance |
| Q34079289 | Concentration-dependent dual effects of hydrogen peroxide on insulin signal transduction in H4IIEC hepatocytes |
| Q36309322 | Consequences of food energy excess and positive energy balance |
| Q44598192 | Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. |
| Q36434450 | Contribution of CB1 blockade to the management of high-risk abdominal obesity |
| Q44044410 | Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease |
| Q51559659 | Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. |
| Q37794985 | Control of lipid storage and cell size between adipocytes by vesicle-associated glycosylphosphatidylinositol-anchored proteins. |
| Q89944427 | Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver |
| Q44927558 | Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up |
| Q44518209 | Coronary capillary network remodeling and hypofibrinolysis in aged obese diabetic rats: implications for increased myocardial vulnerability to ischemia |
| Q46743811 | Coronary endothelial dysfunction and impaired microcirculation response to atrial natriuretic peptide in hyperinsulinemia |
| Q48275677 | Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischemic stroke |
| Q37408791 | Correlation between insulin-induced estrogen receptor methylation and atherosclerosis |
| Q44144311 | Correlation of hair mineral concentrations with insulin resistance in Korean males |
| Q44340900 | Correlations between surrogate measures of insulin resistance and cardiovascular risk factors in obese and overweight patients |
| Q45173117 | Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations |
| Q41736007 | Current concepts of polycystic ovary syndrome |
| Q37313185 | Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults |
| Q53849595 | Decreased insulin sensitivity is associated with the extent of coronary artery disease in patients with angina. |
| Q43594324 | Defining health-related obesity in prepubertal children |
| Q46563275 | Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients |
| Q41283425 | Diabetes and dyslipidemia: characterizing lipoprotein metabolism |
| Q33762031 | Diabetes and ischemic heart disease |
| Q33836508 | Diabetes in the elderly population. |
| Q33983641 | Diabetes mellitus and coronary heart disease--from prevention to intervention: Part I. |
| Q34332579 | Diabetes mellitus: a major challenge in transplantation |
| Q33652018 | Diabetes, hyperlipidemia, and coronary artery disease |
| Q34245190 | Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies |
| Q35179563 | Diagnosis, prevention, and intervention for the metabolic syndrome |
| Q57415514 | Dietary glycaemic index from an epidemiological point of view |
| Q37365823 | Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study. |
| Q45960597 | Differential structural and functional changes in penile and coronary arteries from obese Zucker rats. |
| Q35874893 | Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study. |
| Q28534604 | Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models |
| Q51552229 | Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet. |
| Q43320670 | Does C-reactive protein identify a subclinical metabolic disease in healthy subjects? |
| Q51443873 | Does the metabolic syndrome predict mobility impairment in the elderly? |
| Q44423210 | Effect of Metformin and Sulfonylurea on C-Reactive Protein Level in Well-Controlled Type 2 Diabetics with Metabolic Syndrome |
| Q33758962 | Effect of St. John's Wort (Hypericum perforatum) on obesity, lipid metabolism and uterine epithelial proliferation in ovariectomized rats |
| Q33375701 | Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study |
| Q52865882 | Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease. |
| Q44397622 | Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia |
| Q43557302 | Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X. |
| Q44507316 | Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity |
| Q42165361 | Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women |
| Q36199995 | Effect of vitamins a, C, and e supplementation in the treatment of metabolic syndrome in albino rats |
| Q35890886 | Effects of Acute Ingestion of Native Banana Starch on Glycemic Response Evaluated by Continuous Glucose Monitoring in Obese and Lean Subjects |
| Q44530878 | Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort |
| Q36507849 | Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients |
| Q36717912 | Effects of Synbiotics on Inflammatory Markers in Patients With Type 2 Diabetes Mellitus |
| Q37612020 | Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus |
| Q51385895 | Effects of a therapeutic lifestyle modification program on inflammatory chemokines and insulin resistance in subjects with metabolic syndrome. |
| Q58737724 | Effects of alternate day calorie restriction and exercise on cardio-metabolic risk factors in overweight and obese adults: an exploratory randomized controlled study |
| Q36633079 | Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial |
| Q34511337 | Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X. |
| Q44049495 | Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study |
| Q30420069 | Effects of diet-induced obesity on protein expression in insulin signaling pathways of skeletal muscle in male Wistar rats |
| Q33843664 | Effects of exercise and cardiac rehabilitation on cardiovascular outcomes |
| Q79299400 | Effects of exercise and cardiac rehabilitation on cardiovascular outcomes |
| Q47828353 | Effects of glucose and insulin on rat apolipoprotein A-I gene expression. |
| Q43161306 | Effects of increasing dietary protein and fibre intake with lupin on body weight and composition and blood lipids in overweight men and women. |
| Q46173029 | Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea |
| Q46877809 | Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux |
| Q54053967 | Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients. |
| Q74083062 | Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats |
| Q44704999 | Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism |
| Q37690775 | Emerging cardiometabolic complications of androgen deprivation therapy |
| Q37423408 | Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. |
| Q35588998 | Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease |
| Q51489577 | Endothelial lipase is associated with inflammation in humans. |
| Q47246787 | Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes. |
| Q41486221 | Energy expenditure, body composition, and disease risk in children and adolescents |
| Q54120421 | Enhanced insulin response to oral glucose load in patients with angina pectoris associated with ST segment elevation in the absence of epicardial coronary arterial obstruction. |
| Q53697048 | Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina. |
| Q37445535 | Entero-insular axis and postprandial insulin differences in African American and European American children |
| Q33694770 | Epidemiology of insulin resistance and its relation to coronary artery disease |
| Q41388533 | Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs |
| Q77052053 | Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance |
| Q35087486 | Epidemiology of the insulin resistance syndrome |
| Q44776392 | Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population |
| Q46278993 | Ethnic differences in body composition and other markers of cardiovascular disease risk: study in matched Haitian and White subjects from Quebec |
| Q44389360 | Evidence for distinct genetic effects on obesity and lipid-related CVD risk factors in diabetic compared to nondiabetic American Indians: the Strong Heart Family Study |
| Q73279178 | Evidence for joint action of genes on diabetes status and CVD risk factors in American Indians: the Strong Heart Family Study |
| Q51557186 | Evidence of pleiotropic loci for fasting insulin, total fat mass, and abdominal visceral fat in a sedentary population: the HERITAGE family study. |
| Q34071541 | Evidence that triglycerides are an independent coronary heart disease risk factor |
| Q44038995 | Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia |
| Q34379604 | Exercise in weight management of obesity |
| Q49834393 | Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function |
| Q39649800 | Factor analysis of possible risks for hypertension in a black South African population |
| Q44536731 | Fasting and daylong triglycerides in obesity with and without type 2 diabetes |
| Q44146844 | Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women. |
| Q35159345 | Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance |
| Q44477343 | Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children |
| Q36317996 | Features of the metabolic syndrome and the risk of cardiovascular disease |
| Q34027250 | Fibrinolytic function and coronary risk |
| Q44686551 | Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients |
| Q33545583 | From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus |
| Q40832213 | Functional food science and substrate metabolism |
| Q41068208 | Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. |
| Q43971013 | Genes and coronary heart disease |
| Q35239129 | Genetic and environmental architecture of the features of the insulin-resistance syndrome |
| Q34586819 | Genetic determinants of diabetes and atherosclerosis |
| Q58715441 | Genetic variation in 9p21 is associated with fasting insulin in women but not men |
| Q43762454 | Global risk assessment in the presymptomatic patient |
| Q52865880 | Glycaemic index as a determinant of serum HDL-cholesterol concentration. |
| Q35737628 | Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline. |
| Q34994750 | Glycemic index in chronic disease: a review |
| Q34617897 | Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome? |
| Q30426632 | Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus |
| Q34133528 | HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. |
| Q45397600 | Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study |
| Q34147834 | Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. |
| Q78251625 | High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population |
| Q35180591 | High-insulinogenic nutrition--an etiologic factor for obesity and the metabolic syndrome? |
| Q81477237 | High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes |
| Q73128305 | Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47) |
| Q51562432 | Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. |
| Q33797998 | Hyperhomocysteinemia as a Metabolic Risk Factor for Glucose Intolerance Among High-Risk Groups of Chinese Adults |
| Q44660105 | Hyperhomocysteinemia as a component of syndrome X |
| Q44287719 | Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: The Malmö Preventive Project |
| Q48698986 | Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta |
| Q36806457 | Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice |
| Q54081357 | Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. |
| Q37875205 | Hyperinsulinemia, lipoprotein (a), and Chlamydia pneumoniae antibodies--are they risk factors or serologic predictors for progression of coronary artery disease? |
| Q34105474 | Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? |
| Q73156915 | Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease |
| Q46890214 | Hypersensitivity of prediabetic JCR:LA-cp rats to fine airborne combustion particle-induced direct and noradrenergic-mediated vascular contraction. |
| Q50871006 | Hypertension and insulin resistance in a native unindustrialised rural population of India. |
| Q37158219 | Hypertension in rheumatoid arthritis. |
| Q46926320 | Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women. |
| Q73887951 | Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy |
| Q35721055 | Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases |
| Q37671150 | Hypogonadism and metabolic syndrome in nigerian male patients with both type 2 diabetes and hypertension |
| Q34027319 | Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease |
| Q33597449 | Identification of glucose transporter 4 knockdown-dependent transcriptional activation element on the retinol binding protein 4 gene promoter and requirement of the 20 S proteasome subunit for transcriptional activity |
| Q40313878 | Impact of follow-up time and re-measurement of the electrocardiogram and conventional cardiovascular risk factors on their predictive value for myocardial infarction |
| Q77176461 | Impact of kidney-pancreas transplantation on the progression of peripheral vascular disease in diabetic patients with end-stage renal disease |
| Q44800842 | Impact of portal venous pancreas graft drainage on kidney graft outcome in simultaneous pancreas-kidney recipients reported to UNOS. |
| Q44255046 | Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women |
| Q54053962 | Impaired HDL response to fat in men with coronary artery disease. |
| Q43988560 | Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats |
| Q33880869 | Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? |
| Q36415843 | Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes |
| Q44438580 | Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke |
| Q45223762 | Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species |
| Q35577429 | Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial |
| Q73858874 | Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species |
| Q32016616 | Improvement of left ventricular diastolic dynamics in prediabetic stage of a type II diabetic rat model after troglitazone treatment |
| Q43929649 | Improvement of vascular dysfunction and blood lipids of insulin-resistant rats by a marine oil-based phytosterol compound |
| Q36697588 | Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy |
| Q57605783 | In obese and non-obese adults, the cis-regulatory rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes |
| Q44517927 | Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome |
| Q45218165 | Incidence of insulin resistance in obese subjects in a rural Japanese population: the Tanno and Sobetsu study |
| Q35922205 | Increased atherosclerosis and endothelial dysfunction in mice bearing constitutively deacetylated alleles of Foxo1 gene |
| Q28577455 | Increased expression of CCAAT/enhancer binding protein-beta and -delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats |
| Q36052731 | Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats. |
| Q44320967 | Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients |
| Q53920487 | Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. |
| Q44676653 | Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism |
| Q43990996 | Influence of type 2 diabetes mellitus on cardiovascular disease mortality: findings from the Hawaii-Los Angeles-Hiroshima study |
| Q46646892 | Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells |
| Q44599804 | Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways |
| Q90315993 | Insulin Clearance After Oral and Intravenous Glucose Following Gastric Bypass and Gastric Banding Weight Loss |
| Q41432967 | Insulin Resistance in Early Rheumatoid Arthritis Is Associated with Low Appendicular Lean Mass |
| Q41089691 | Insulin Sensitivity Determines Effects of Insulin and Meal Ingestion on Systemic Vascular Resistance in Healthy Subjects |
| Q41718753 | Insulin and coronary artery disease: is syndrome X the unifying hypothesis? |
| Q28167207 | Insulin and insulin resistance: impact on blood pressure and cardiovascular disease |
| Q35676828 | Insulin as an anti-inflammatory and antiatherosclerotic hormone |
| Q36908280 | Insulin decreases atherosclerosis by inducing endothelin receptor B expression. |
| Q51561534 | Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. |
| Q44755613 | Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase |
| Q24318872 | Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile |
| Q35586455 | Insulin receptor and ageing |
| Q41258320 | Insulin resistance |
| Q64264442 | Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study |
| Q55280246 | Insulin resistance and coronary artery disease in non-diabetic patients: Is there any correlation? |
| Q43554448 | Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease |
| Q36756593 | Insulin resistance and hyperinsulinemia: you can't have one without the other |
| Q37371843 | Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). |
| Q44183635 | Insulin resistance and its involvement in multiple risk factors associated with type 2 diabetes mellitus |
| Q34920100 | Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study |
| Q51540941 | Insulin resistance and vessel endothelial function. |
| Q37000702 | Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis |
| Q58136275 | Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease |
| Q46755096 | Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients |
| Q41579716 | Insulin resistance implications for type II diabetes mellitus and coronary heart disease |
| Q50940040 | Insulin resistance in adult polycystic kidney disease. |
| Q73943146 | Insulin resistance in patients with familial combined hyperlipidemia and coronary artery disease |
| Q43086768 | Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis. |
| Q40158270 | Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease. |
| Q36232060 | Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study |
| Q80224109 | Insulin resistance syndrome in children and adolescents: clinical meaning and indication for action |
| Q33938941 | Insulin resistance syndrome, body mass index and the risk of ischemic heart disease |
| Q35976473 | Insulin resistance, cystatin C, and mortality among older adults |
| Q37193499 | Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study. |
| Q46946681 | Insulin resistance, obesity, and related disorders among black adolescents |
| Q81065477 | Insulin resistance, premature adrenarche, and a risk of the Polycystic Ovary Syndrome (PCOS) |
| Q54074092 | Insulin resistance-associated hepatic iron overload. |
| Q38626570 | Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes |
| Q34163104 | Insulin resistance: an independent risk factor for cardiovascular disease? |
| Q42462735 | Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet |
| Q51566677 | Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects. |
| Q46415645 | Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp |
| Q35676832 | Insulin therapy for reducing cardiovascular risk in patients with type 2 diabetes |
| Q35219417 | Insulin therapy for type 2 diabetes |
| Q36014899 | Insulin treatment and cardiovascular disease; friend or foe? A point of view. |
| Q36383552 | Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function |
| Q37268071 | Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells |
| Q51562983 | Insulin-like growth factor-I lowers fasting and postprandial triglyceride levels without affecting chylomicron clearance in healthy men. |
| Q51559070 | Insulin-mediated vasodilation and glucose uptake are independently related to fasting serum nonesterified fatty acids in elderly men. |
| Q43864993 | Insulin-metformin combination therapy in obese patients with type 2 diabetes |
| Q99235477 | Integrating anthropometric and cardiometabolic health methods in stress, early experiences, and development (SEED) science |
| Q27860882 | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group |
| Q44574966 | Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity |
| Q35053417 | Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children |
| Q54348266 | Involvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation. |
| Q42104171 | Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats. |
| Q51564428 | Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? |
| Q35366993 | Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. |
| Q54122646 | Issues surrounding tight glycemic control in people with type 2 diabetes mellitus. |
| Q44393967 | Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients |
| Q45192302 | Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in Type 1 diabetic subjects |
| Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
| Q34990620 | Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance |
| Q44133905 | Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes |
| Q49358967 | Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene. |
| Q34485920 | Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice |
| Q96132907 | Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals |
| Q35212563 | Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease |
| Q35087365 | Management of the insulin resistance syndrome |
| Q47638569 | Managing and treating risk and uncertainty for health: a case study of diabetes among First Nation's people in Ontario, Canada |
| Q34125415 | Managing myocardial infarction in the diabetic patient |
| Q29028203 | Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization |
| Q93138049 | Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids |
| Q35149077 | Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction |
| Q24616159 | Metabolic complications of androgen deprivation therapy for prostate cancer |
| Q33904956 | Metabolic complications of obesity. Pathophysiologic considerations |
| Q51496839 | Metabolic consequences of pancreatic systemic or portal venous drainage in simultaneous pancreas-kidney transplant recipients. |
| Q34962416 | Metabolic effects of androgen deprivation therapy |
| Q51570177 | Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus. |
| Q51370538 | Metabolic factors and high-sensitivity C-reactive protein: the HUNT study. |
| Q33962557 | Metabolic phenotype in the brothers of women with polycystic ovary syndrome |
| Q37431937 | Metabolic sequelae associated with androgen deprivation therapy for prostate cancer |
| Q35319301 | Metabolic syndrome and cancer |
| Q37885168 | Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. |
| Q33607601 | Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness |
| Q36674821 | Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? |
| Q36755551 | Metabolic syndrome: why the controversy? |
| Q51325737 | Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. |
| Q46663023 | Metformin improves endothelial function in patients with metabolic syndrome. |
| Q22241434 | Metformin: new understandings, new uses |
| Q43889886 | Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly? |
| Q36952365 | Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia |
| Q51390966 | Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test |
| Q47756026 | Mitogenic factors accelerate later-age diseases: insulin as a paradigm |
| Q34989681 | Molecular mechanisms of diabetic cardiovascular disease |
| Q42577172 | Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy |
| Q41592358 | Myocardial blood flow and glucose metabolism in diabetes mellitus |
| Q46984037 | Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs |
| Q40846304 | Nephropathy and hypertension in diabetes |
| Q35814941 | Neuronal and Endothelial Nitric Oxide Synthases in the Paraventricular Nucleus Modulate Sympathetic Overdrive in Insulin-Resistant Rats |
| Q37067669 | New directions in the treatment of heart failure: targeting free fatty acid oxidation |
| Q46866221 | New trends in insulin resistance: the role of mineralocorticoids |
| Q33453482 | Newer insights into the drug delivery approaches of α-glucosidase inhibitors |
| Q44053871 | Obesity affects myocardial vasoreactivity and coronary flow response to insulin |
| Q78318718 | Obesity and cardiovascular disease |
| Q34034147 | Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications |
| Q36005149 | Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanisms |
| Q44705316 | Obesity modulates the association among APOE genotype, insulin, and glucose in men. |
| Q44279278 | Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children |
| Q34028181 | Obesity, hypertension, and vascular disease |
| Q46887042 | Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q34087245 | Optimising therapy for insulin-treated type 2 diabetes mellitus |
| Q37069180 | Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities |
| Q36697741 | Oral antidiabetic agents as cardiovascular drugs |
| Q34143860 | Orlistat: selective inhibition of caloric absorption can affect long-term body weight |
| Q43719489 | Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease |
| Q46643723 | Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats. |
| Q34336860 | Pathophysiology and treatment of the dyslipidemia of insulin resistance |
| Q41611236 | Pharmacological treatment and mechanisms of insulin resistance. Impact on vascular smooth muscle cells, blood pressure, and lipids |
| Q31049211 | Phenotypic, genetic, and genome-wide structure in the metabolic syndrome |
| Q33792222 | Physical activity, cardiometabolic health and older adults: recent findings |
| Q51573506 | Physiological hyperinsulinemia is not associated with alterations in venous plasma levels of endothelin-1 in healthy individuals. |
| Q34620604 | Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin |
| Q43889895 | Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study |
| Q44148753 | Plasma glucose and insulin responses to mixed meals: impaired fasting glucose re-visited |
| Q30941905 | Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies |
| Q43687657 | Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. |
| Q73228440 | Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan--The Taipei Children Heart Study |
| Q46054334 | Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome. |
| Q34384926 | Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease |
| Q35181647 | Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk |
| Q51552850 | Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. |
| Q35584209 | Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus |
| Q44298323 | Postchallenge hyperglycemia but not hyperinsulinemia is associated with angiographically documented coronary atherosclerosis in Korean subjects |
| Q47145958 | Postprandial Blood Glucose Outweighs Fasting Blood Glucose and HbA1c in screening Coronary Heart Disease |
| Q44416279 | Postprandial triglycerides in response to high fat: role of dietary carbohydrate |
| Q35087456 | Prediabetes mellitus and its links to atherosclerosis |
| Q33848252 | Predicting the occurrence of diabetes mellitus in recipients of heart transplants |
| Q74013954 | Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study |
| Q43045641 | Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia. |
| Q46863166 | Prevalence of cardiovascular risk factors in the Balearic Islands (CORSAIB Study) |
| Q34057915 | Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old |
| Q46388253 | Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension |
| Q39489191 | Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects |
| Q35614308 | Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care |
| Q33859347 | Prevention of coronary heart disease. Part I. Primary prevention |
| Q41611170 | Progress in population analyses of the insulin resistance syndrome |
| Q35707809 | Progress with thiazolidinediones in the management of type 2 diabetes mellitus |
| Q37390104 | Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy |
| Q28366557 | Protection of vascular wall function in insulin-resistant rats from copper oxidative stress |
| Q34659350 | Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice |
| Q44391891 | QUICKI is a useful index of insulin sensitivity in subjects with hypertension |
| Q48246268 | RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by Hemodiafiltration |
| Q44260265 | Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism |
| Q26999467 | Recent pharmacological developments on rhodanines and 2,4-thiazolidinediones |
| Q37898749 | Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing? |
| Q44954444 | Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. |
| Q41886965 | Relation between Delayed Superfluous Insulin Secretion during An Oral Glucose Tolerance Test and Metabolic Disorders in Obese Japanese Children |
| Q51532521 | Relation between insulin and aortic stiffness: a population-based study. |
| Q44448300 | Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study |
| Q37169408 | Relation of insulin resistance with social-demographics, adiposity and behavioral factors in non-diabetic adult Canadians. |
| Q44584075 | Relation of leptin to insulin resistance syndrome in children |
| Q33608611 | Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review |
| Q51572081 | Relationship between changes in physical activity and plasma insulin during a 2.5-year follow-up study. |
| Q44198033 | Relationship between insulin resistance and accumulation of coronary risk factors |
| Q74269420 | Relationship between lipid peroxidation and plasma fibrinogen in middle-aged men |
| Q44133524 | Relationship between obesity, insulin resistance, and coronary heart disease risk |
| Q57236015 | Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men |
| Q50888007 | Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population. Associazione Medica Sabin. |
| Q51566000 | Relationships between the pituitary-adrenal hormones, insulin, and glucose in middle-aged men: moderating influence of psychosocial stress. |
| Q73545640 | Relationships of C-peptide levels and the C-peptide/bloodsugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well-controlled type 2 diabetic patients |
| Q51324982 | Relationships of hair mineral concentrations with insulin resistance in metabolic syndrome. |
| Q30405237 | Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial |
| Q47671233 | Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians. |
| Q43833311 | Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes |
| Q73326755 | Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus |
| Q73279174 | Restored insulin inhibition on insulin secretion in nondiabetic severely obese patients after weight loss induced by bariatric surgery |
| Q33608692 | Retinol binding protein 4 promotes hyperinsulinism‑induced proliferation of rat aortic smooth muscle cells |
| Q28540249 | Retracted: Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters |
| Q43052194 | Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome |
| Q35107210 | Risk Factors for Coronary Artery Disease in Patients with Renal Failure |
| Q39490721 | Risk factors correlated with risk of insulin resistance using homeostasis model assessment in adolescents in Taiwan |
| Q33764951 | Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) |
| Q34157757 | Risk factors for vascular disease in patients with diabetes |
| Q44657553 | Role of Adiponectin in Insulin-Resistant Hypertension and Atherosclerosis |
| Q33937011 | Role of PC-1 in the etiology of insulin resistance |
| Q73975779 | Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus |
| Q34955658 | Rosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin Resistance |
| Q44814371 | Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats |
| Q48002594 | Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism |
| Q36135440 | Salt restriction among hypertensive patients: modest blood pressure effect and no adverse effects |
| Q54132799 | Salt sensitivity: concept and pathogenesis. |
| Q37778985 | Salt, aldosterone, and insulin resistance: impact on the cardiovascular system |
| Q51546937 | Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study. |
| Q34753635 | Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice |
| Q36930826 | Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture |
| Q28593272 | Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells |
| Q43857793 | Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus |
| Q92771839 | Serum insulin levels are associated with vulnerable plaque components in the carotid artery: the Rotterdam Study |
| Q77714845 | Serum lipid physiology and the influence of glaucoma medications |
| Q74156319 | Serum lipids, serum insulin, plasma fibrinogen and aerobic capacity in obese and non-obese Singaporean boys |
| Q24309211 | Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes |
| Q41646633 | Short-Term Estrogen Withdrawal Increases Adiposity in Healthy Men. |
| Q51575122 | Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia. |
| Q30423117 | Should all women with PCOS be treated for insulin resistance? |
| Q35673800 | Should the insulin resistance syndrome be treated in the elderly? |
| Q36411670 | Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model |
| Q37243305 | Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation? |
| Q46793873 | Smoking, fasting serum insulin, and obesity are the predictors of carotid atherosclerosis in relatively young subjects |
| Q34541875 | Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus. |
| Q34069026 | Strength training in the elderly: effects on risk factors for age-related diseases |
| Q34556500 | Subclinical Diabetes |
| Q73062347 | Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects |
| Q44929714 | Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome |
| Q35900829 | Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice. |
| Q51482065 | Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. |
| Q60647431 | Systemic hypertension and coronary artery disease: the link |
| Q47289966 | Systolic and diastolic blood pressure related to six other risk parameters in Turkish adults: strong correlation with relative weight |
| Q43759228 | Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle |
| Q38925481 | Targeting hepatic glucose metabolism in the treatment of type 2 diabetes |
| Q51474535 | Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. |
| Q34491335 | Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial |
| Q55710950 | The Cut-off Values of Surrogate Measures for Insulin Sensitivity in a Healthy Population in Korea according to the Korean National Health and Nutrition Examination Survey (KNHANES) 2007-2010. |
| Q41431039 | The Deidesheimer meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus |
| Q57502562 | The Impact of Central Obesity as a Prerequisite for the Diagnosis of Metabolic Syndrome* |
| Q37478476 | The Quebec Heart Institute: 50 years of excellence in cardiology |
| Q88447727 | The Reaven syndrome: a tribute to a giant |
| Q37560012 | The Role of Immunogenicity in Cardiovascular Disease |
| Q55175780 | The association between insulin resistance, metabolic syndrome, and ischemic heart disease among Rumoi residents. |
| Q78044101 | The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients |
| Q37355184 | The cutoff values of indirect indices for measuring insulin resistance for metabolic syndrome in Korean children and adolescents |
| Q46003012 | The deadly quartet revisited. |
| Q28196575 | The effect of insulin resistance on prognosis of non-diabetic patients who underwent percutaneous coronary intervention |
| Q51571044 | The effect of transdermal 17-beta-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration. |
| Q44178808 | The effects of errors in lipid measurement and assessment |
| Q80769593 | The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation |
| Q36545395 | The effects of thiazolidinediones on blood pressure levels - a systematic review |
| Q33614139 | The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials |
| Q33537653 | The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders |
| Q44360342 | The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity |
| Q36749236 | The evolving definitions and increasing prevalence of the metabolic syndrome. |
| Q34761708 | The fractionalization of physical activity throughout the week is associated with the cardiometabolic health of children and youth |
| Q37710264 | The glycemic index: physiological significance |
| Q36025991 | The impact of antidiabetic therapies on cardiovascular disease |
| Q42114446 | The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population |
| Q46758647 | The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease |
| Q41756032 | The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk |
| Q26823862 | The interplay of autoimmunity and insulin resistance in type 1 diabetes |
| Q34775069 | The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular disease |
| Q36394352 | The metabolic basis of atherogenic dyslipidemia |
| Q36459414 | The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care |
| Q37362674 | The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? |
| Q36218262 | The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes |
| Q35029797 | The obesity epidemic: pathophysiology and consequences of obesity |
| Q44983748 | The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population |
| Q39440870 | The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern Nigerians |
| Q40078479 | The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. |
| Q47777020 | The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension |
| Q51556361 | The role of obesity in the association of cardiovascular risk factors and glucose intolerance in small Japanese and North American communities. |
| Q37808552 | The role of vascular failure in coronary artery spasm |
| Q33752794 | The use of insulin alone and in combination with oral agents in type 2 diabetes |
| Q34315432 | Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. |
| Q36178550 | Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance |
| Q36378641 | Treating the spectrum of type 2 diabetes: emphasis on insulin pump therapy |
| Q33588554 | Troglitazone: a review of its use in the management of type 2 diabetes mellitus |
| Q41730147 | Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cells |
| Q51568226 | Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease. |
| Q51527048 | Type 2 Diabetes Mellitus and Insulin Resistance: Stroke Prevention and Management. |
| Q35767308 | Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic |
| Q58100959 | Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion |
| Q64257959 | Understanding Human Physiological Limitations and Societal Pressures in Favor of Overeating Helps to Avoid Obesity |
| Q34524535 | Update on the cardiometabolic syndrome |
| Q51559973 | Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study. |
| Q74397668 | Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus |
| Q37122213 | Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort) |
| Q33273785 | Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study |
| Q51327721 | Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. |
| Q77098045 | Vascular disease and lipids in diabetes |
| Q33616816 | Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe. |
| Q46988898 | Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL. |
| Q34034922 | Visceral obesity and the risk of ischaemic heart disease: insights from the Québec Cardiovascular Study |
| Q36613084 | Vitamin D replacement in Asians with diabetes may increase insulin resistance |
| Q74012803 | Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study |
| Q47265442 | Weight gain and insulin resistance during nicotine replacement therapy. |
| Q38865934 | What Is the Effect of Metabolic Syndrome without Hypertension on Left Ventricular Hypertrophy? |
| Q35124783 | Whole grains protect against atherosclerotic cardiovascular disease |
| Q54004598 | [Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives] |
| Q42361224 | db/db Mice Exhibit Features of Human Type 2 Diabetes That Are Not Present in Weight-Matched C57BL/6J Mice Fed a Western Diet |